Abbott's Sturgis plant to resume production of baby formula after entering into consent decree

4 June, 2022
Share with a friend

Abbott's Sturgis plant to resume production of baby formula after entering into consent decree

Abbott Nutrition announced today that it will resume production at their formula plant in Sturgis after entering into a consent decree with the U.S. Food and Drug Administration.

"Our number one priority is getting infants and families the high-quality formulas they need, and this is a major step toward re-opening our Sturgis facility so we can ease the nationwide formula shortage. We look forward to working with the FDA to quickly and safely re-open the facility," said Robert B. Ford, chairman and chief executive officer, Abbott. "We know millions of parents and caregivers depend on us and we're deeply sorry that our voluntary recall worsened the nationwide formula shortage. We will work hard to re-earn the trust that moms, dads and caregivers have placed in our formulas for more than 50 years."


Share with a friend